Trials / Completed
CompletedNCT00595790
Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51
Phase 3 Study to Compare a Rapid Immunization Regime With the Standard Regime of IC51 as Vaccine for Japanese Encephalitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 374 (actual)
- Sponsor
- Valneva Austria GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The study investigates a rapid immunization regime of the Japanese Encephalitis vaccine IC51 (JE-PIV) in healthy subjects aged \> or = 18 years
Detailed description
This is a multicenter, observer blinded, controlled, randomized phase 3 study. The study population consists of healthy male and female volunteers, aged at least 18 years. Approximately 375 volunteers will be enrolled at approximately 2 to 3 sites.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | IC51 |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2006-02-01
- Completion
- 2007-11-01
- First posted
- 2008-01-16
- Last updated
- 2014-04-29
- Results posted
- 2014-03-26
Source: ClinicalTrials.gov record NCT00595790. Inclusion in this directory is not an endorsement.